Screener
Vir Biotechnology, Inc. VIR Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| CURRENT LIABILITIES: | ||
| Accounts payable | $17,754 | $9,803 |
| Accrued and other liabilities | 77,207 | 83,012 |
| Total current liabilities | 94,961 | 92,815 |
| Operating lease liabilities, noncurrent | 84,137 | 89,054 |
| Contingent consideration obligation, noncurrent | 34,340 | 34,100 |
| Other long-term liabilities | 18,875 | 21,578 |
| TOTAL LIABILITIES | 232,313 | 237,547 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Vir Biotechnology, Inc.'s total current liabilities?
- Vir Biotechnology, Inc. (VIR) reported total current liabilities of $94.96M in Q2 2026.
- How has Vir Biotechnology, Inc.'s total current liabilities changed year-over-year?
- Vir Biotechnology, Inc.'s total current liabilities decreased by 9.6% year-over-year, from $105M to $94.96M.
- What is the long-term trend for Vir Biotechnology, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s total current liabilities has grown at a -1.3% compound annual growth rate (CAGR), from $99.06M to $92.82M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Vir Biotechnology, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude